Nivata IPO Market Data

MainboardBSE, NSEOpen

Moneyview Limited - Corrigendum to RHP and Price Band
IPO GMP & Details

Check Moneyview Limited - Corrigendum to RHP and Price Band IPO GMP and its recorded history, price band, issue dates, total subscription, lot size and listing date. Unofficial GMP is not a listing forecast.

StatusOpen Listing1 Oct 2026 Page updated4 Oct 2026

At a glance

Moneyview Limited - Corrigendum to RHP and Price Band IPO details

StatusOpen
Price band₹32 – ₹34
Opens24 Sep 2026
Closes28 Sep 2026
Total issue size₹1091.68 Cr
Lot size441 shares
Overall subscription6.01× subscribed
ExchangeBSE, NSE

Issue schedule & market details

Moneyview Limited - Corrigendum to RHP and Price Band IPO key data

These are structured market-data fields. Missing values are left blank rather than estimated.

Issue typeMainboard
ExchangeBSE, NSE
Price band₹32 – ₹34
Lot size441 shares
Issue size₹1091.68 Cr
Open date24 Sep 2026
Close date28 Sep 2026
Listing date1 Oct 2026
Overall subscription6.01× subscribed

Quick facts

Moneyview Limited - Corrigendum to RHP and Price Band IPO FAQs

When does the Moneyview Limited - Corrigendum to RHP and Price Band IPO open and close?

The opening date is 24 Sep 2026. The closing date is 28 Sep 2026.

When is the Moneyview Limited - Corrigendum to RHP and Price Band IPO listing date?

The currently recorded listing date is 1 Oct 2026. The timetable can change if the issue schedule is revised.

What is the Moneyview Limited - Corrigendum to RHP and Price Band IPO price band?

The currently recorded price band is ₹32 – ₹34.

What is the Moneyview Limited - Corrigendum to RHP and Price Band IPO lot size?

The recorded lot size is 441 shares. Review the official issue terms before applying.

What is the Moneyview Limited - Corrigendum to RHP and Price Band IPO subscription?

Nivata currently records overall issue subscription at 6.01 times. This is not an allotment probability.

IPO market data

This page contains factual IPO schedule, pricing, subscription, listing and GMP information. It does not contain an IPO research article and does not provide a recommendation, rating, target price, valuation conclusion, expected return, listing forecast, allotment probability or a view on whether to participate in the issue.

← View all IPO GMP, current & upcoming IPOs